Huahai Pharma adjusts convertible bond price, suspends trading

Zhejiang Huahai Pharmaceutical (SSE:600521) announced an adjustment to the conversion price of its "Huahai Convertible Bonds" (SSE:110076) from CNY 33.21 to CNY 33.31 per share, effective June 17, 2025. The adjustment stems from the cancellation of 10,656,753 repurchased shares. Trading of the convertible bonds will be suspended on June 16, 2025, and will resume on June 17, 2025. The company's board of directors assures investors that the announcement contains no false or misleading information. The bonds, with a total issuance of 18,426,000, were originally issued on November 2, 2020, and are set to mature on November 1, 2026, with the possibility of conversion to shares from May 6, 2021, through November 1, 2026.